ClinicalTrials.gg
Not yet recruitingNCT07099352Updated Aug 4, 2026

Efficacy of of Acupuncture Laser Therapy on Hemodialysis Patients

An interventional study of Acupuncture Laser Therapy in Hemodialysis, sponsored by Sinai University. Not yet recruiting at 1 site in Egypt. Open to participants aged Up to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-04.

Sponsored by Sinai University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
Up to 60 Years
Sex
All
01

Study summary

This expected prospective randomized control trial study will involve 60 haemodialysis patients with neck pain. The patients in the experimental group (E) will subject, medical treatment besides acupuncture laser therapy. Medical treatment will be used in the control group (C). Pain and quality of life assessment will be used in the assessment of outcome.

Read the detailed description

The present study will carry out on 60 participants with Haemodialysis that will treat in Hehia hospital that is specialized in physical therapy for Hemodialysis. sixty hemodialysis patients undergoing physical therapy treatments will participate in the study. Their mean age will range from (18-65) years old. The exclusion criteria were as follows: a failure to take part in more than three light therapy sessions; a kidney transplant; and death.

02

Conditions studied

  • Hemodialysis

Keywords

  • Hemodialysis, Acupuncture Laser Therapy
03

In context

Lead sponsor

Sinai University is the lead sponsor of 24 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-Their mean age will range from (18-65) years old.

Exclusion criteria

Exclusion Criteria:

-a failure to take part in more than three light therapy sessions; a kidney transplant; and death.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Efficacy of of Acupuncture Laser Therapy on Hemodialysis

    This expected prospective randomized control trial study will involve 60 hemodialysis patients with neck pain. The patients in the experimental group (E) will subject, medical treatment besides acupuncture laser therapy. Medical treatment will be used in the control group (C). Pain and quality of life assessment will be used in the assessment of outcome.

    Device: Acupuncture Laser Therapy

Interventions

  • DeviceAcupuncture Laser Therapy

    Participants will receive low-level laser therapy sessions during dialysis , applied three times per week for 4 weeks to selected treatment areas.

06

What researchers measure

Primary outcomes

  1. change in pain scales

    visual analogue scale

    Time frame: baseline and after 2 weeks of treatment

  2. change in Quality of life scale

    Chronic neck pain is a common issue among individuals undergoing hemodialysis, often resulting from factors such as poor posture during treatments, muscle tension, and underlying health conditions. Traditional pain management strategies may not always provide adequate relief and can have undesirable side effects, especially in patients with complex medical histories.

    Time frame: baseline and after 2 weeks of treatment

  3. change of perceived stress scale

    Chronic neck pain is a common issue among individuals undergoing hemodialysis, often resulting from factors such as poor posture during treatments, muscle tension, and underlying health conditions. Traditional pain management strategies may not always provide adequate relief and can have undesirable side effects, especially in patients with complex medical histories.

    Time frame: Baseline and after 4 weeks of treatment

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — sixty patients undergoing physical therapy treatments in Hehia hospital will participate in the study. Their mean age will range from (18-65) years old. The exclusion criteria were as follows: a failure to take part in more than three light therapy sessions; a kidney transplant; and death.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07099352
Lead sponsor
Sinai University
Responsible party
Amany Gomaa Atiaa (Academic researcher, Sinai University) — Principal investigator
First posted
Aug 1, 2025
Start date
Aug 3, 2026 (estimated)
Primary completion
Aug 1, 2027 (estimated)
Completion
Oct 1, 2027 (estimated)
Last update
Aug 4, 2026

Study contacts

Shimaa Galal Elsayed, lecturer
Contact
shimaagalal1986@gmail.com
+20-100-311-9152

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion